Company / Working Capital
Incyte Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$3.5B
FY2025
5-year range
$1.6B / $3.5B
FY2021-FY2025
Trend
+119.7%
vs FY2024
Sector context
#13 of 213
Health Care
What the data says
Among 213 Health Care companies, Incyte is in the top 6% for working capital. Working Capital has fluctuated over the past 10 years, ranging from $721M in FY2016 to $3.5B in FY2025.
Based on SEC 10-K filings.
$3.5B in FY2025 with a 5-year CAGR of +15.2%. Top quartile in the Health Care sector.
Improved from $3.4B to $3.5B over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +6.1%
- 5-Year CAGR
- +15.2%
- 10-Year CAGR
- -
Sector benchmark
Top 6% in Health CareTop 6% of 213This company $3.5B Sector average $934.6M
▼
+275.4% above sector average
Key checks
Key Insights
- 5-year CAGR of +15.2%, indicating consistent growth.
- In FY2025, working capital increased 119.7% year-over-year.
- Ranks #13 out of 213 companies in the Health Care sector.
- Lowest working capital in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.01 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.7%
- Strong return on equity: 25.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.5B | +119.7% |
| FY2024 | $1.6B | -53.1% |
| FY2023 | $3.4B | +16.0% |
| FY2022 | $2.9B | +29.7% |
| FY2021 | $2.3B | +31.0% |
| FY2020 | $1.7B | -12.2% |
| FY2019 | $2.0B | +39.9% |
| FY2018 | $1.4B | +24.6% |
| FY2017 | $1.1B | +56.7% |
| FY2016 | $720.7M | +6.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026